1. Waking the giant: business model innovation in the drug industry;Lindgardt;In Vivo,2008
2. QuintilesIMS Institute. Outlook for Global Medicines through 2021. https://morningconsult.com/wp-content/uploads/2016/12/QuintilesIMS-Institute-Global-Outlook-FINAL.pdf. Published December 2016. Accessed December 26, 2017.
3. R&D Briefing 59: The impact of the evolving regulatory environment on the approval of new medicines across six major authorities 2006-2015;Bujar;Centre for Innovation in Regulatory Science,2016
4. Pharmaceutical Pricing and Reimbursement in Japan: For Faster, More Complete Access to New Drugs;Takayama;Ther Innov Regul Sci,2015
5. Recent approaches by the PMDA to promoting new drug development: changes in the status of the PMDA in relation to new drug development over the last five years;Mori;Drug Inf J,2009